News

Innovus Pharmaceuticals announced the launch of its lidocaine-based cream Xyralid, for the relief of pain and symptoms caused by hemorrhoids. Xyralid received a Product License…
Read More...

Family-owned pharmaceutical company Boehringer Ingelheim presented its latest pipeline updates at a Research & Development press conference entitled ‘Transcending Disease…
Read More...

GlaxoSmithKline plc and Innoviva announced that the US Food and Drug Administration (FDA) has approved an expanded indication for Trelegy Ellipta (fluticasone…
Read More...

ADC Therapeutics (ADCT), an oncology drug discovery and development company that specializes in the development of proprietary Antibody Drug Conjugates (ADCs) targeting major cancers,…
Read More...

AstraZeneca and MedImmune announced high-level results from the Phase III ARCTIC trial in patients with locally-advanced or metastatic non-small cell lung cancer (NSCLC) who have…
Read More...

AMRI will expand its nuclear magnetic resonance (NMR) spectroscopy capabilities in Europe with the addition of the Bruker AVANCE NEO 600 MHz NMR Spectrometer. “NMR is a core…
Read More...

Grand River Aseptic Manufacturing has announced its second major equipment purchase this year: a state-of-the-art Bausch+Ströbel fully integrated high-speed filling line with SKAN…
Read More...

Zymeworks Inc. announced that Celgene Corporation has exercised its right to expand its collaboration agreement for the research, development, and commercialization of bispecific…
Read More...

Noramco and SPI Pharma have signed an agreement to develop and license a set of “value-added” formulation packages for global pharmaceutical manufacturers of finished dosage forms.…
Read More...

Q Therapeutics and REPROCELL announced the formation of MAGiQ Therapeutics, Inc., a Japanese joint venture company. MAGiQ will develop iPSC-derived, glial-restricted progenitor cells…
Read More...

Advent International and Sanofi have entered into exclusive negotiations under which Advent would acquire Zentiva, Sanofi’s European generics business for €1,919 million.  Advent’s…
Read More...

NovaDigm Therapeutics announced the initiation of a Phase 2a study evaluating NDV-3A for the reduction of Staphylococcus aureus (S. aureus) colonization in a high-risk population of…
Read More...

Phoenix Molecular Designs (PhoenixMD) announced that it has entered into a collaboration with STA Pharmaceutical Co., Ltd (STA), a WuXi AppTec group company, to manufacture the PMD-026…
Read More...

Sinovac Biotech Ltd. announced preliminary results of a phase III clinical study on Sabin inactivated polio vaccine developed by Sinovac Biotech on the unblinding conference held on…
Read More...

Contract development and manufacturing organisation (CDMO) Sterling Pharma Solutions is investing £6m into its pilot plant facility at its UK site to enhance its scale-up and small to…
Read More...

KinderPharm LLC, dedicated exclusively to pediatric clinical research, and Worldwide Clinical Trials Inc. (Worldwide), an award-winning, full-service CRO, announced that they have…
Read More...

Germfree has released bioGO this week in New York at INTERPHEX. The biomanufacturing platform represents a completely new approach to quick and flexible production space. The company…
Read More...

AstraZeneca announced that the US Food and Drug Administration (FDA) has approved Tagrisso (osimertinib) for the 1st-line treatment of patients with metastatic non-small cell…
Read More...

Roche announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to Hemlibra (emicizumab-kxwh) for people with haemophilia A without factor…
Read More...

Sandoz, a Novartis division, announced that it has entered into a collaboration with Pear Therapeutics to commercialize and continued development of novel prescription digital…
Read More...